CTOs on the Move

Pearson Pilings

www.pearsonpilings.com

 
Pearson Pilings is a Fall River, MA-based company in the Business Services sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

CFO Selections

CFO Selections is a Bellevue, WA-based company in the Business Services sector.

Quality Machinery Sales Inc

Quality Machinery Sales Inc is a Centreville, VA-based company in the Business Services sector.

Bajaj Consumer Care

Bajaj Consumer Care is the second largest company in the Shishir Bajaj Group of companies. The history of Bajaj Consumer Care dates back to 1953 when Mr. Kamalnayan Bajaj established Bajaj Sevashram to market and sell hair oils and other beauty products. Bajaj Consumer Care Ltd. is one of the leading player in Hair oil category with brands like Bajaj Almond Drops Hair Oil, Bajaj Brahmi Amla Hair Oil, Bajaj Amla Hair oil and Bajaj Jasmine Hair oil. Our flagship Brand Bajaj Almond Drops Hair oil is the No. 1* hair oil in Indian market with Premium positioning and commands one of the highest per unit price in the industry.

Niagara Geriatric Center

Niagara Geriatric Center is a Niagara Falls, NY-based company in the Business Services sector.

Cellerant

Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.